What does 3-D Matrix, Ltd. do?

3-D Matrix, Ltd. (DMTRF) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is DMTRF's market cap?

3-D Matrix, Ltd. (DMTRF) has a market capitalization of approximately $320.0 million, as of August 25, 2026, based on the most recent share price and shares outstanding.

Does DMTRF pay a dividend?

No — 3-D Matrix, Ltd. (DMTRF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

DMTRF

3-D Matrix, Ltd.

OTC·Biotechnology · Healthcare

$2.50$0.00+0.00%

Market cap$319.95M·Market closed·Aug 25 8:00 PM UTC

Price Chart

$2.50+$0.00 (+0.00%)today

−2.34%CAGR −0.47%

Select date range

FromTo

Jun 19, 2013Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DMTRF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateSep 16

Last Report DateJun 11

Reported vs Estimate$0.09

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥10.88B

Net Income¥4.15B

Net Margin38.2%

Operating Cash Flow¥0.00

Capital Expenditures¥0.00

Free Cash Flow¥0.00

Return on Equity61.2%

Return on Invested Capital8.4%

Net Cash¥2.23B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for DMTRF and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how DMTRF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DMTRF and 80,000+ other tickers.

About 3-D Matrix, Ltd.

3-D Matrix, Ltd. specializes in advancing self-assembling peptide technology. The company's primary offering is PuraMatrix, an innovative self-assembling peptide hydrogel utilized across diverse medical sectors such as regenerative medicine, cell-based therapies, sophisticated drug delivery mechanisms, and various surgical applications. This Tokyo, Japan-based entity was founded in 2004.

CEO: Toshihiko Amanuma
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 129
Website: www.3d-matrix.co.jp

Peers

Peers Tab

AONC

American Oncology Network, Inc.

Cap

$380.2M

ONVVF

Oneview Healthcare PLC

Cap

$122.8M

ABTI

Alterola Biotech, Inc.

Cap

$291.9K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About DMTRF

What does 3-D Matrix, Ltd. do?: 3-D Matrix, Ltd. (DMTRF) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is DMTRF's market cap?: 3-D Matrix, Ltd. (DMTRF) has a market capitalization of approximately $320.0 million, as of August 25, 2026, based on the most recent share price and shares outstanding.
Does DMTRF pay a dividend?: No — 3-D Matrix, Ltd. (DMTRF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.